Titre : Cholestase

Cholestase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Acute Disease

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer la cholestase ?

Le diagnostic repose sur des tests sanguins, échographies et biopsies hépatiques.
Cholestase Biopsie hépatique
#2

Quels tests sanguins sont utilisés ?

Les tests incluent les niveaux de bilirubine, ALAT, ASAT et phosphatases alcalines.
Bilirubine Tests sanguins
#3

L'échographie est-elle utile ?

Oui, l'échographie permet de visualiser les voies biliaires et détecter des obstructions.
Échographie Voies biliaires
#4

Quand faire une biopsie hépatique ?

Une biopsie est envisagée si la cause de la cholestase n'est pas claire après d'autres tests.
Biopsie hépatique Cholestase
#5

Quels signes cliniques indiquent une cholestase ?

Les signes incluent jaunisse, prurit, et douleurs abdominales.
Jaunisse Prurit

Symptômes 5

#1

Quels sont les symptômes de la cholestase ?

Les symptômes incluent jaunisse, démangeaisons, fatigue et douleurs abdominales.
Jaunisse Démangeaisons
#2

La cholestase cause-t-elle des démangeaisons ?

Oui, l'accumulation de sels biliaires dans le sang provoque des démangeaisons.
Démangeaisons Sels biliaires
#3

Peut-on avoir des douleurs abdominales ?

Oui, des douleurs dans la partie supérieure droite de l'abdomen peuvent survenir.
Douleurs abdominales Cholestase
#4

La fatigue est-elle un symptôme ?

Oui, la fatigue est fréquente en raison de l'accumulation de toxines dans le sang.
Fatigue Cholestase
#5

Y a-t-il des signes de malnutrition ?

Oui, une malabsorption des graisses peut entraîner des carences nutritionnelles.
Malnutrition Malabsorption

Prévention 5

#1

Comment prévenir la cholestase ?

Prévenir les maladies hépatiques et maintenir un mode de vie sain aide à réduire le risque.
Prévention Maladies hépatiques
#2

L'alimentation joue-t-elle un rôle ?

Oui, une alimentation équilibrée et riche en fibres peut soutenir la santé hépatique.
Alimentation Santé hépatique
#3

Faut-il éviter certains médicaments ?

Oui, certains médicaments peuvent aggraver la cholestase, consultez un médecin.
Médicaments Cholestase
#4

Les examens réguliers sont-ils importants ?

Oui, des examens réguliers du foie peuvent aider à détecter des problèmes précocement.
Examens réguliers Foie
#5

Le contrôle du poids est-il essentiel ?

Oui, maintenir un poids santé réduit le risque de maladies hépatiques et de cholestase.
Contrôle du poids Maladies hépatiques

Traitements 5

#1

Quels traitements existent pour la cholestase ?

Les traitements incluent des médicaments, des changements alimentaires et parfois la chirurgie.
Médicaments Chirurgie
#2

Les médicaments peuvent-ils aider ?

Oui, des médicaments comme l'acide ursodéoxycholique peuvent améliorer l'écoulement biliaire.
Acide ursodéoxycholique Médicaments
#3

Quand envisager une intervention chirurgicale ?

La chirurgie est envisagée en cas d'obstruction des voies biliaires ou de lésions hépatiques.
Chirurgie Obstruction des voies biliaires
#4

Un régime alimentaire peut-il aider ?

Oui, un régime pauvre en graisses peut réduire les symptômes et améliorer la digestion.
Régime alimentaire Cholestase
#5

Des suppléments sont-ils recommandés ?

Des suppléments de vitamines liposolubles peuvent être nécessaires en cas de malabsorption.
Suppléments Vitamines liposolubles

Complications 5

#1

Quelles complications peuvent survenir ?

Les complications incluent la cirrhose, l'insuffisance hépatique et des infections.
Cirrhose Insuffisance hépatique
#2

La cholestase peut-elle causer des infections ?

Oui, l'accumulation de bile peut favoriser des infections des voies biliaires.
Infections Voies biliaires
#3

Y a-t-il un risque de cirrhose ?

Oui, une cholestase prolongée peut entraîner une cirrhose et des dommages hépatiques irréversibles.
Cirrhose Cholestase
#4

L'insuffisance hépatique est-elle possible ?

Oui, une cholestase sévère peut conduire à une insuffisance hépatique aiguë ou chronique.
Insuffisance hépatique Cholestase
#5

Des problèmes de coagulation peuvent-ils survenir ?

Oui, la cholestase peut affecter la production de facteurs de coagulation, augmentant le risque de saignement.
Coagulation Cholestase

Facteurs de risque 5

#1

Quels sont les facteurs de risque de cholestase ?

Les facteurs incluent l'obésité, l'alcoolisme, et certaines maladies hépatiques.
Obésité Maladies hépatiques
#2

L'âge influence-t-il le risque ?

Oui, le risque de cholestase augmente avec l'âge, surtout chez les personnes âgées.
Âge Cholestase
#3

Les femmes sont-elles plus à risque ?

Oui, certaines formes de cholestase, comme la cholestase gravidique, touchent plus les femmes.
Cholestase gravidique Femmes
#4

Les maladies auto-immunes sont-elles un facteur ?

Oui, des maladies comme la cholangite sclérosante peuvent augmenter le risque de cholestase.
Maladies auto-immunes Cholangite sclérosante
#5

Le tabagisme influence-t-il le risque ?

Oui, le tabagisme peut aggraver les maladies hépatiques et augmenter le risque de cholestase.
Tabagisme Maladies hépatiques
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cholestase : Questions médicales les plus fréquentes", "headline": "Cholestase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cholestase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-27", "dateModified": "2024-12-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cholestase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies des canaux biliaires", "url": "https://recherchemedicale.com/mesh/D001649", "about": { "@type": "MedicalCondition", "name": "Maladies des canaux biliaires", "code": { "@type": "MedicalCode", "code": "D001649", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.130.120" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cholestase extrahépatique", "alternateName": "Cholestasis, Extrahepatic", "url": "https://recherchemedicale.com/mesh/D001651", "about": { "@type": "MedicalCondition", "name": "Cholestase extrahépatique", "code": { "@type": "MedicalCode", "code": "D001651", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.130.120.135.150" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Mirizzi", "alternateName": "Mirizzi Syndrome", "url": "https://recherchemedicale.com/mesh/D057792", "about": { "@type": "MedicalCondition", "name": "Syndrome de Mirizzi", "code": { "@type": "MedicalCode", "code": "D057792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C06.130.120.135.812" } } } ], "about": { "@type": "MedicalCondition", "name": "Cholestase", "alternateName": "Cholestasis", "code": { "@type": "MedicalCode", "code": "D002779", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Eva Gijbels", "url": "https://recherchemedicale.com/author/Eva%20Gijbels", "affiliation": { "@type": "Organization", "name": "Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium." } }, { "@type": "Person", "name": "Mathieu Vinken", "url": "https://recherchemedicale.com/author/Mathieu%20Vinken", "affiliation": { "@type": "Organization", "name": "Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium." } }, { "@type": "Person", "name": "Pieter Annaert", "url": "https://recherchemedicale.com/author/Pieter%20Annaert", "affiliation": { "@type": "Organization", "name": "Drug Delivery & Disposition, Department of Pharmaceutical & Pharmacological Sciences, Katholieke Universiteit Leuven, ON II Herestraat 49, Box 921, Leuven, 3000, Belgium." } }, { "@type": "Person", "name": "Verena Keitel", "url": "https://recherchemedicale.com/author/Verena%20Keitel", "affiliation": { "@type": "Organization", "name": "Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty at Heinrich-Heine-University, Düsseldorf, Germany. Verena.Keitel@med.uni-duesseldorf.de." } }, { "@type": "Person", "name": "Alanah Pieters", "url": "https://recherchemedicale.com/author/Alanah%20Pieters", "affiliation": { "@type": "Organization", "name": "Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Standardizing process in acute biliary disease.", "datePublished": "2023-12-26", "url": "https://recherchemedicale.com/article/38686809", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/wjs.12049" } }, { "@type": "ScholarlyArticle", "name": "Mitochondrial quality control in acute kidney disease.", "datePublished": "2023-02-17", "url": "https://recherchemedicale.com/article/36800104", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40620-023-01582-3" } }, { "@type": "ScholarlyArticle", "name": "[Intensive care management of acute diseases of the aorta].", "datePublished": "2023-02-03", "url": "https://recherchemedicale.com/article/36735023", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00101-023-01253-9" } }, { "@type": "ScholarlyArticle", "name": "Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury.", "datePublished": "2022-02-23", "url": "https://recherchemedicale.com/article/35217065", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jhep.2022.02.009" } }, { "@type": "ScholarlyArticle", "name": "Posttraumatic Stress Disorder as a Consequence of Acute Cardiovascular Disease.", "datePublished": "2023-05-02", "url": "https://recherchemedicale.com/article/37129760", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11886-023-01870-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil digestif", "item": "https://recherchemedicale.com/mesh/D004066" }, { "@type": "ListItem", "position": 3, "name": "Maladie des voies biliaires", "item": "https://recherchemedicale.com/mesh/D001660" }, { "@type": "ListItem", "position": 4, "name": "Maladies des canaux biliaires", "item": "https://recherchemedicale.com/mesh/D001649" }, { "@type": "ListItem", "position": 5, "name": "Cholestase", "item": "https://recherchemedicale.com/mesh/D002779" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cholestase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cholestase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cholestase", "description": "Comment diagnostiquer la cholestase ?\nQuels tests sanguins sont utilisés ?\nL'échographie est-elle utile ?\nQuand faire une biopsie hépatique ?\nQuels signes cliniques indiquent une cholestase ?", "url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Acute+Disease#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cholestase", "description": "Quels sont les symptômes de la cholestase ?\nLa cholestase cause-t-elle des démangeaisons ?\nPeut-on avoir des douleurs abdominales ?\nLa fatigue est-elle un symptôme ?\nY a-t-il des signes de malnutrition ?", "url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Acute+Disease#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cholestase", "description": "Comment prévenir la cholestase ?\nL'alimentation joue-t-elle un rôle ?\nFaut-il éviter certains médicaments ?\nLes examens réguliers sont-ils importants ?\nLe contrôle du poids est-il essentiel ?", "url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Acute+Disease#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cholestase", "description": "Quels traitements existent pour la cholestase ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nUn régime alimentaire peut-il aider ?\nDes suppléments sont-ils recommandés ?", "url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Acute+Disease#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cholestase", "description": "Quelles complications peuvent survenir ?\nLa cholestase peut-elle causer des infections ?\nY a-t-il un risque de cirrhose ?\nL'insuffisance hépatique est-elle possible ?\nDes problèmes de coagulation peuvent-ils survenir ?", "url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Acute+Disease#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cholestase", "description": "Quels sont les facteurs de risque de cholestase ?\nL'âge influence-t-il le risque ?\nLes femmes sont-elles plus à risque ?\nLes maladies auto-immunes sont-elles un facteur ?\nLe tabagisme influence-t-il le risque ?", "url": "https://recherchemedicale.com/mesh/D002779?mesh_terms=Acute+Disease#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la cholestase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, échographies et biopsies hépatiques." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent les niveaux de bilirubine, ALAT, ASAT et phosphatases alcalines." } }, { "@type": "Question", "name": "L'échographie est-elle utile ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'échographie permet de visualiser les voies biliaires et détecter des obstructions." } }, { "@type": "Question", "name": "Quand faire une biopsie hépatique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie est envisagée si la cause de la cholestase n'est pas claire après d'autres tests." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une cholestase ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent jaunisse, prurit, et douleurs abdominales." } }, { "@type": "Question", "name": "Quels sont les symptômes de la cholestase ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent jaunisse, démangeaisons, fatigue et douleurs abdominales." } }, { "@type": "Question", "name": "La cholestase cause-t-elle des démangeaisons ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'accumulation de sels biliaires dans le sang provoque des démangeaisons." } }, { "@type": "Question", "name": "Peut-on avoir des douleurs abdominales ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs dans la partie supérieure droite de l'abdomen peuvent survenir." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue est fréquente en raison de l'accumulation de toxines dans le sang." } }, { "@type": "Question", "name": "Y a-t-il des signes de malnutrition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une malabsorption des graisses peut entraîner des carences nutritionnelles." } }, { "@type": "Question", "name": "Comment prévenir la cholestase ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Prévenir les maladies hépatiques et maintenir un mode de vie sain aide à réduire le risque." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée et riche en fibres peut soutenir la santé hépatique." } }, { "@type": "Question", "name": "Faut-il éviter certains médicaments ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent aggraver la cholestase, consultez un médecin." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers du foie peuvent aider à détecter des problèmes précocement." } }, { "@type": "Question", "name": "Le contrôle du poids est-il essentiel ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un poids santé réduit le risque de maladies hépatiques et de cholestase." } }, { "@type": "Question", "name": "Quels traitements existent pour la cholestase ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, des changements alimentaires et parfois la chirurgie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme l'acide ursodéoxycholique peuvent améliorer l'écoulement biliaire." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée en cas d'obstruction des voies biliaires ou de lésions hépatiques." } }, { "@type": "Question", "name": "Un régime alimentaire peut-il aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime pauvre en graisses peut réduire les symptômes et améliorer la digestion." } }, { "@type": "Question", "name": "Des suppléments sont-ils recommandés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de vitamines liposolubles peuvent être nécessaires en cas de malabsorption." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la cirrhose, l'insuffisance hépatique et des infections." } }, { "@type": "Question", "name": "La cholestase peut-elle causer des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'accumulation de bile peut favoriser des infections des voies biliaires." } }, { "@type": "Question", "name": "Y a-t-il un risque de cirrhose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une cholestase prolongée peut entraîner une cirrhose et des dommages hépatiques irréversibles." } }, { "@type": "Question", "name": "L'insuffisance hépatique est-elle possible ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une cholestase sévère peut conduire à une insuffisance hépatique aiguë ou chronique." } }, { "@type": "Question", "name": "Des problèmes de coagulation peuvent-ils survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la cholestase peut affecter la production de facteurs de coagulation, augmentant le risque de saignement." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de cholestase ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, l'alcoolisme, et certaines maladies hépatiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de cholestase augmente avec l'âge, surtout chez les personnes âgées." } }, { "@type": "Question", "name": "Les femmes sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines formes de cholestase, comme la cholestase gravidique, touchent plus les femmes." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la cholangite sclérosante peuvent augmenter le risque de cholestase." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les maladies hépatiques et augmenter le risque de cholestase." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 24/12/2024

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Eva Gijbels

4 publications dans cette catégorie

Affiliations :
  • Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium.
Publications dans "Cholestase" :

Mathieu Vinken

4 publications dans cette catégorie

Affiliations :
  • Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium.
Publications dans "Cholestase" :

Pieter Annaert

3 publications dans cette catégorie

Affiliations :
  • Drug Delivery & Disposition, Department of Pharmaceutical & Pharmacological Sciences, Katholieke Universiteit Leuven, ON II Herestraat 49, Box 921, Leuven, 3000, Belgium.
Publications dans "Cholestase" :

Verena Keitel

3 publications dans cette catégorie

Affiliations :
  • Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty at Heinrich-Heine-University, Düsseldorf, Germany. Verena.Keitel@med.uni-duesseldorf.de.
Publications dans "Cholestase" :

Alanah Pieters

2 publications dans cette catégorie

Affiliations :
  • Department of In Vitro Toxicology & Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium.
Publications dans "Cholestase" :

Bruno Cogliati

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology, School of Veterinary Medicine & Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva 87, Cidade Universitária, SP, 05508-270, Brazil.
Publications dans "Cholestase" :

Lindsey Devisscher

2 publications dans cette catégorie

Affiliations :
  • Basic & Applied Medical Sciences, Gut-Liver Immunopharmacology Unit, Faculty of Medicine & Health Sciences, Ghent University, C Heymanslaan 10, Ghent, 9000, Belgium.
Publications dans "Cholestase" :

Giovanni Vitale

2 publications dans cette catégorie

Affiliations :
  • Internal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • European Reference Network on Hepatological Diseases (ERN RARE-LIVER), 20246 Hamburg, Germany.
Publications dans "Cholestase" :

Moinak Sen Sarma

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India.
Publications dans "Cholestase" :

Anshu Srivastava

2 publications dans cette catégorie

Affiliations :
  • Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India.
Publications dans "Cholestase" :

T Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai 201102, China.
Publications dans "Cholestase" :

J S Wang

2 publications dans cette catégorie

Affiliations :
  • Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai 201102, China.
Publications dans "Cholestase" :

Ronald P J Oude Elferink

2 publications dans cette catégorie

Affiliations :
  • Amsterdam University Medical Centers, Tytgat Institute for Liver and Intestinal Research, Research Institute Amsterdam Gastroenterology, Endocrinology and Metabolism (AGEM), University of Amsterdam, Amsterdam, Netherlands.
Publications dans "Cholestase" :

Xiao Ma

2 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Cholestase" :

Wenwen Zhang

2 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Cholestase" :

None None

2 publications dans cette catégorie

Publications dans "Cholestase" :

Amy G Feldman

2 publications dans cette catégorie

Affiliations :
  • Digestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, CO.

Ronald J Sokol

2 publications dans cette catégorie

Affiliations :
  • Digestive Health Institute, Children's Hospital Colorado, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Aurora, CO.

James E Squires

2 publications dans cette catégorie

Affiliations :
  • Division of Gastroenterology, Hepatology, and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, United States. james.squires2@chp.edu.
Publications dans "Cholestase" :

Ulrich Beuers

2 publications dans cette catégorie

Affiliations :
  • Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands. u.h.beuers@amsterdamumc.nl.
Publications dans "Cholestase" :

Sources (10000 au total)

Standardizing process in acute biliary disease.

The perioperative management of biliary disease (BD) is variable across institutions with suboptimal outcomes for patients and health care systems. This results in inefficient utilization of limited r... Data were prospectively captured at Christchurch Hospital for all adult patients presenting for cholecystectomy between May 2015 and May 2022. Pre, post, and intraoperative factors were assessed for t... Four thousand five hundred seventy-seven patients underwent cholecystectomy during the study period, of which 2807 (61%) were acute presentations and made up the cohort for analysis. Time to theater w... Standardizing management of BD would likely result in significant savings for the health care system and improved outcomes for patients. The data seen here evidence the importance of appropriate imagi...

Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury.

Acute kidney disease (AKD) is the persistence of acute kidney injury (AKI) for up to 3 months, which is proposed to be the time-window where critical interventions can be initiated to alter downstream... Hospitalized patients with cirrhosis and AKI in the Cerner-Health-Facts database from 1/2009-09/2017 (n = 6,250) were assessed for AKD and were followed-up for 180 days. AKI and AKD were defined based... AKD developed in 32% of our cohort. On multivariable competing-risk analysis adjusting for significant confounders, patients with AKD had higher risk of mortality at 90 (subdistribution hazard ratio [... AKD develops in 1 in 3 hospitalized patients with cirrhosis and AKI and it is associated with worse survival and de novo CKD. Interventions that target AKD may improve outcomes of patients with cirrho... In a nationwide US cohort of hospitalized patients with cirrhosis and acute kidney injury, acute kidney disease developed in 1 in 3 patients and was associated with worse survival and chronic kidney d...

Posttraumatic Stress Disorder as a Consequence of Acute Cardiovascular Disease.

To provide an update of the current evidence of cardiac disease-induced posttraumatic stress disorder (CDI-PTSD) with a focus on acute coronary events.... A cardiovascular disease, particularly a life-threatening cardiac event is often a highly stressful experience that can induce PTSD in patients and their caregivers, taking a chronic course if left un...

Risk factors for development of acute kidney injury and acute kidney disease in critically ill children.

Acute kidney injury (AKI) is common among critically ill children and these children are at risk of developing acute kidney disease (AKD).... A prospective cohort study was conducted on children aged > 1 month to ≤ 18 years old admitted to the pediatric intensive care unit (ICU) of Hong Kong Children's Hospital from 6/2020 to 6/2021. The in... There were 254 eligible admissions (58.3% in males, with a median age of 4.9 [9.7] years). The overall AKI incidence was 41.7% and 56% of children who remained hospitalized in the pediatric ICU for ≥ ... AKI and AKD were common among critically ill children, and were associated with significant morbidity and mortality. Few modifiable risk factors, especially those related to nephrotoxic medication exp...

Specialist-led urgent cholecystectomy for acute gallstone disease.

Despite overwhelming evidence of the clinical and financial benefit of urgent cholecystectomy, there is variable enthusiasm and uptake across the UK. In 2014, following the First National Emergency La... Computerised operating theatre records were interrogated to identify all patients within a 5-year period undergoing cholecystectomy. Patient demographics, admission details, length of stay, duration o... Between 01/01/2016 and 31/12/2020, a total of 4870 cholecystectomies were performed; 1793 (36.8%) were urgent cases and 3077 (63.2%) were elective cases. All cases were started laparoscopically; 25 (0... Urgent laparoscopic cholecystectomy is safe and feasible in most patients with acute gall bladder disease. Surgery under the direct care of upper gastrointestinal specialist surgeons is associated wit...

Quality indicators for acute cardiovascular diseases: a scoping review.

Although many quality indicator (QI) sets have been developed for acute cardiovascular diseases, a comprehensive summary is lacking. In this scoping review we aimed to summarize the available evidence... We conducted a systematic search of MEDLINE, EMBASE, and major international guidelines on QIs for acute major cardiovascular diseases. The study included articles published after 2000.... Among the 3112 articles screened, 18 were included in this scoping review. Among the 18 articles included, 12 were on acute coronary syndrome (ACS), five on acute heart failure (AHF), and two on acute... This scoping review provides a comprehensive list of QIs for acute cardiovascular diseases. Our results may be helpful to clinicians and organizations seeking to develop QIs for acute cardiovascular c...

High risk and low prevalence diseases: Acute chest syndrome in sickle cell disease.

Acute chest syndrome (ACS) in sickle cell disease (SCD) is a serious condition that carries with it a high rate of morbidity and mortality.... This review highlights the pearls and pitfalls of ACS in SCD, including diagnosis and management in the emergency department (ED) based on current evidence.... ACS is defined by respiratory symptoms and/or fever and a new radiodensity on chest imaging in a patient with SCD. There are a variety of inciting causes, including infectious and non-infectious etiol... An understanding of ACS can assist emergency clinicians in diagnosing and managing this potentially deadly disease....

Patient level factors increase risk of acute kidney disease in hospitalized children with acute kidney injury.

Studies in adults have shown that persistent kidney dysfunction ≥7-90 days following acute kidney injury (AKI), termed acute kidney disease (AKD), increases chronic kidney disease (CKD) and mortality ... Retrospective cohort study of children age ≤18 years admitted with AKI to all pediatric units at a single tertiary-care children's hospital between 2015 and 2019. Exclusion criteria included insuffici... A total of 528 children with AKI were included in the study. There were 297 (56.3%) hospitalized AKI survivors who developed AKD. Among children with AKD, 45.5% developed CKD compared to 18.7% in the ... AKD is common among hospitalized children with AKI and multiple risk factors are associated with AKD. Children that progress from AKI to AKD are at higher risk of developing CKD. A higher resolution v...